BR112015028551A2 - derivados de pirimidin-4-il)óxi)-1h-indol-1-carboxamida e usos dos mesmos - Google Patents
derivados de pirimidin-4-il)óxi)-1h-indol-1-carboxamida e usos dos mesmosInfo
- Publication number
- BR112015028551A2 BR112015028551A2 BR112015028551A BR112015028551A BR112015028551A2 BR 112015028551 A2 BR112015028551 A2 BR 112015028551A2 BR 112015028551 A BR112015028551 A BR 112015028551A BR 112015028551 A BR112015028551 A BR 112015028551A BR 112015028551 A2 BR112015028551 A2 BR 112015028551A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyrimidin
- oxy
- indol
- methyl
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
a b s t r a c t this invention relates to certain metabolites of n-(1-methyl-5-(trifluoromethyl)-1h-pyrazol-3-yl)-5-((6-((methylamino)methyl)pyrimidin-4-yl)oxy)-1h-indole-1-carboxamide in particular, the present invention relates to pharmaceutical compositions comprising these metabolites, as well as processes for their preparation and their use in the treatment of diseases. tradução do resumo resumo patente de invenção: "derivados de pirimidin-4-il)óxi)-1h-indol-1-carboxamida e usos dos mesmos". a presente invenção refere-se a certos metabolitos de n-(1-metil-5-(trifluorometil)-1h-pirazol-3-il)-5-((6-((metilamino)metil)pirimidin-4-yl)oxy)-1h-indol-1-carboxamida. em particular, a presente invenção refere-se a composições farmacêuticas compreendendo estes metabolitos, bem como processos para a sua preparação e ao seu uso no tratamento de doenças.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361824464P | 2013-05-17 | 2013-05-17 | |
PCT/IB2014/061484 WO2014184778A1 (en) | 2013-05-17 | 2014-05-16 | Pyrimidin-4-yl)oxy)-1h-indole-1-carboxamide derivatives and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015028551A2 true BR112015028551A2 (pt) | 2017-07-25 |
Family
ID=50896374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015028551A BR112015028551A2 (pt) | 2013-05-17 | 2014-05-16 | derivados de pirimidin-4-il)óxi)-1h-indol-1-carboxamida e usos dos mesmos |
Country Status (13)
Country | Link |
---|---|
US (2) | US20150018376A1 (pt) |
EP (1) | EP2997022B1 (pt) |
JP (1) | JP2016518443A (pt) |
KR (1) | KR20160010522A (pt) |
CN (1) | CN105452241B (pt) |
AR (1) | AR096322A1 (pt) |
AU (1) | AU2014266867B2 (pt) |
BR (1) | BR112015028551A2 (pt) |
CA (1) | CA2912130A1 (pt) |
EA (1) | EA201592190A1 (pt) |
ES (1) | ES2699776T3 (pt) |
MX (1) | MX2015015845A (pt) |
WO (1) | WO2014184778A1 (pt) |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1524747A (en) | 1976-05-11 | 1978-09-13 | Ici Ltd | Polypeptide |
PT72878B (en) | 1980-04-24 | 1983-03-29 | Merck & Co Inc | Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents |
ATE28864T1 (de) | 1982-07-23 | 1987-08-15 | Ici Plc | Amide-derivate. |
GB8327256D0 (en) | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
US5093330A (en) | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
US5010099A (en) | 1989-08-11 | 1991-04-23 | Harbor Branch Oceanographic Institution, Inc. | Discodermolide compounds, compositions containing same and method of preparation and use |
NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
AU661533B2 (en) | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
TW225528B (pt) | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
GB9314893D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
WO1996030347A1 (en) | 1995-03-30 | 1996-10-03 | Pfizer Inc. | Quinazoline derivatives |
GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
US5843901A (en) | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
DK0836605T3 (da) | 1995-07-06 | 2002-05-13 | Novartis Ag | Pyrrolopyrimidiner og fremgangsmåder til deres fremstilling |
US5760041A (en) | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
EP0892789B2 (en) | 1996-04-12 | 2009-11-18 | Warner-Lambert Company LLC | Irreversible inhibitors of tyrosine kinases |
DE69734513T2 (de) | 1996-06-24 | 2006-07-27 | Pfizer Inc. | Phenylamino-substituierte tricyclische derivate zur behandlung hyperproliferativer krankheiten |
JP2001500851A (ja) | 1996-08-30 | 2001-01-23 | ノバルティス アクチエンゲゼルシャフト | エポシロンの製造法および製造過程中に得られる中間生産物 |
EP0938597B1 (en) | 1996-09-06 | 2003-08-20 | Obducat Aktiebolag | Method for anisotropic etching of structures in conducting materials |
WO1998010767A2 (en) | 1996-09-13 | 1998-03-19 | Sugen, Inc. | Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders |
EP0837063A1 (en) | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazoline derivatives |
AU753546B2 (en) | 1996-11-18 | 2002-10-24 | Helmholtz-Zentrum Fuer Infektionsforschung Gmbh | Epothilone C, D, E and F, production process, and their use as cytostatic as well as phytosanitary agents |
US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
CO4940418A1 (es) | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
GB9721069D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Polymeric derivatives of camptothecin |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
DE69927790T2 (de) | 1998-02-25 | 2006-07-20 | Sloan-Kettering Institute For Cancer Research | Synthese von epothilonen, ihren zwischenprodukten und analogen verbindungen |
DE69942097D1 (de) | 1998-08-11 | 2010-04-15 | Novartis Ag | Isochinoline derivate mit angiogenesis-hemmender wirkung |
JP4662635B2 (ja) | 1998-11-20 | 2011-03-30 | コーサン バイオサイエンシーズ, インコーポレイテッド | エポチロンおよびエポチロン誘導体を生成するための組換え方法および材料 |
PE20010306A1 (es) * | 1999-07-02 | 2001-03-29 | Agouron Pharma | Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa |
KR100371449B1 (ko) | 1999-07-20 | 2003-02-07 | 주식회사 아이디어파크 | 무선 이어폰/마이크를 갖는 착탈형 무선전환장치 |
PE20020354A1 (es) | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
TWI238824B (en) | 2001-05-14 | 2005-09-01 | Novartis Ag | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives |
GB0119249D0 (en) | 2001-08-07 | 2001-10-03 | Novartis Ag | Organic compounds |
JP2007524596A (ja) | 2003-02-28 | 2007-08-30 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 共結晶医薬組成物 |
JO3265B1 (ar) * | 2008-12-09 | 2018-09-16 | Novartis Ag | مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض |
-
2014
- 2014-05-14 US US14/277,313 patent/US20150018376A1/en not_active Abandoned
- 2014-05-16 BR BR112015028551A patent/BR112015028551A2/pt not_active IP Right Cessation
- 2014-05-16 CN CN201480040394.1A patent/CN105452241B/zh not_active Expired - Fee Related
- 2014-05-16 EA EA201592190A patent/EA201592190A1/ru unknown
- 2014-05-16 JP JP2016513490A patent/JP2016518443A/ja active Pending
- 2014-05-16 ES ES14728655T patent/ES2699776T3/es active Active
- 2014-05-16 AR ARP140101963A patent/AR096322A1/es unknown
- 2014-05-16 US US14/891,674 patent/US9604969B2/en not_active Expired - Fee Related
- 2014-05-16 WO PCT/IB2014/061484 patent/WO2014184778A1/en active Application Filing
- 2014-05-16 AU AU2014266867A patent/AU2014266867B2/en not_active Ceased
- 2014-05-16 EP EP14728655.3A patent/EP2997022B1/en not_active Not-in-force
- 2014-05-16 MX MX2015015845A patent/MX2015015845A/es unknown
- 2014-05-16 KR KR1020157035366A patent/KR20160010522A/ko not_active Application Discontinuation
- 2014-05-16 CA CA2912130A patent/CA2912130A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2912130A1 (en) | 2014-11-20 |
ES2699776T3 (es) | 2019-02-12 |
MX2015015845A (es) | 2016-06-29 |
EP2997022A1 (en) | 2016-03-23 |
CN105452241A (zh) | 2016-03-30 |
KR20160010522A (ko) | 2016-01-27 |
EA201592190A1 (ru) | 2016-04-29 |
EP2997022B1 (en) | 2018-08-29 |
AU2014266867A1 (en) | 2015-12-03 |
AU2014266867B2 (en) | 2017-07-13 |
AR096322A1 (es) | 2015-12-23 |
CN105452241B (zh) | 2018-01-05 |
WO2014184778A1 (en) | 2014-11-20 |
US20150018376A1 (en) | 2015-01-15 |
US9604969B2 (en) | 2017-03-28 |
US20160115156A1 (en) | 2016-04-28 |
JP2016518443A (ja) | 2016-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015024411A2 (pt) | desaza-purinonas macrocíclicas para o tratamento de infeções virais | |
BR112015020118A2 (pt) | derivados de 2-aminopirimidina para o tratamento de infecções virais | |
BR112015011036A2 (pt) | derivados de 2-amino-quinazolina substituídos heterocíclicos para o tratamento de infecções virais | |
BR112015007366A2 (pt) | derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças | |
BR112015000615A2 (pt) | purinas macrocíclicas para o tratamento de infecções virais | |
BR112014011162A2 (pt) | derivados purínicos para o tratamento de infecções virais | |
BR112015025464A2 (pt) | coagonistas do receptor de glp-1/glucagon estáveis, prolongados para uso médico | |
EA201590343A1 (ru) | Алкилпиримидиновые производные для лечения вирусных инфекций и дальнейших заболеваний | |
EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
PH12015502539B1 (en) | Cenicriviroc compositions and methods of making and using the same | |
EA201391719A1 (ru) | Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний | |
BR112015032546A2 (pt) | derivados de pirrolo[3,2-d]pirimidina para o tratamento de infecções virais e outras doenças | |
BR112015018168A2 (pt) | inibidores de rock suaves | |
EA201690687A1 (ru) | Ингибиторы репликации вируса иммунодефицита | |
BR112013025001A2 (pt) | derivados de pirazolo pirimidina | |
EA201691231A1 (ru) | Фармацевтические лекарственные формы | |
BR112015015250A2 (pt) | derivados de pirrolidina, composições farmacêuticas e usos dos mesmos | |
BR112015028890A2 (pt) | derivados de piridona para o tratamento de infecções virais e outras doenças | |
EA201590752A1 (ru) | Препараты производных пиримидиндиона | |
PH12015501555A1 (en) | Topical aqueous ophthalmic compositions containing a 1h-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease | |
BR112015028551A2 (pt) | derivados de pirimidin-4-il)óxi)-1h-indol-1-carboxamida e usos dos mesmos | |
BR112015008380A2 (pt) | uso de um composto de pirazol[4,3-d]pirimidina tetrassubstituída para o tratamento de nefropatia diabética | |
DOP2016000078A (es) | Formas de dosificación farmacéutica que comprenden 1-[6-(morfolin-4-il)pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)-1h-pirazol-5-olato de sodio | |
CR20160177A (es) | Formas de dosificación farmacéutica que comprenden 1-[6-(morfolin-4-il) pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)1h-pirazol-5-olato de sodio | |
BR112015022000A8 (pt) | preparação de combinação farmacêutica, composição farmacêutica e uso da preparação de combinação |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2514 DE 12-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |